BOULDER, Colo., Feb. 18, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the RBC Capital Markets Global Healthcare and Cowen Annual Healthcare Conferences. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website.
(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)
Event: | RBC Capital Markets Global Healthcare Conference |
Date: | Tuesday, February 25, 2014 |
Time: | 10:30 a.m. Eastern Time |
Location: | New York Palace Hotel, NYC |
Event: | Cowen Annual Healthcare Conference |
Date: | Wednesday, March 5, 2014 |
Time: | 9:20 a.m. Eastern Time |
Location: | Marriott Copley Place Hotel, Boston |
Webcasts: |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Phase 3 or pivotal studies are already in progress, or are planned to begin, within the next year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520), for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (Novartis). For more information on Array, please go to www.arraybiopharma.com
CONTACT: | Tricia Haugeto |
Array BioPharma Inc. | |
303-386-1193 | |
SOURCE Array BioPharma
Help employers find you! Check out all the jobs and post your resume.
